MELISSA RONNEBURG: Open Payments
NPI 1578961736 · JAMESTOWN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $292 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Corcept Therapeutics | 3 | $56 |
| Novo Nordisk Inc | 2 | $53 |
| Hologic Sales and Service, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: Korlym, MAVYRET, Ozempic, APTIMA, Wegovy, QULIPTA, AIRSUPRA, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
